PULSE BIOSCIENCES, INC. (PLSE)
PULSE BIOSCIENCES, INC. (PLSE) from its SEC filings: 2025 revenue $350,000, net margin -20795%, free cash flow -$54.4 million. Insider trades, recent filings and a price chart. Free.
| Exchange | Nasdaq |
| Industry | Surgical & Medical Instruments & Apparatus |
| Revenue (2025) | $350,000 |
| Net income | -$72.8 million |
| Net margin | -20794.6% |
| Free cash flow | -$54.4 million |
| Cash | $101.6 million |
| Share count, 1 year | +6% |
| Fundamentals check | Weak fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-20. Education only, not financial advice.